Blend BPC-157 5mg with Thymosin Beta 4 (TB500) 5mg
Buy Blend BPC-157 5MG with Thymosin Beta 4 (TB500) 5MG:
| Unit Size | 10 mg/vial |
| Unit Quantity | 1 vial |
| Purity (Mass Spectrometry and UV) | 99.77% Nominal Target: 5 mg BPC-157 + 5 mg Thymosin Beta 4 (TB500) |
| Sequence (BPC-157) | H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH |
| Sequence (TB500) | Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys- Gln-Ala-Gly-Glu-Ser-OH |
| Molecular Formula (BPC-157) | C62H98N16O78 |
| Molecular Formula (TB500) | C212H350N56O22 S |
| Appearance | Lyophilized White Powder |
| Source | Chemical Synthesis |
| Storage | Lyophilized Blend BPC-157 5MG with Thymosin Beta 4 (TB500) 5MG is stable at roomTemperature for 90 days, however it is best to store in a freezer below - 8c for any extended period of time. . |
| Terms | The products we offer are intended for laboratory research use only. Please familiarize yourself with our terms of service prior to ordering. |
Blend BPC-157 5mg with Thymosin Beta 4 (TB500) 5mg
View Research Overview & References
This blend combines two synthetic peptides, BPC-157 and Thymosin Beta 4 (TB500), provided exclusively for in vitro and in vivo (animal) laboratory research. This material is intended solely for controlled scientific investigation.
BPC-157 Cell Signaling Research
BPC-157 is a synthetic pentadecapeptide studied in laboratory research for its interaction with cell signaling pathways related to tissue-level cell behavior, including nitric oxide signaling and endothelial cell function.1,2
Thymosin Beta 4 Cytoskeletal Research
Thymosin Beta 4 (TB500) is studied for its interaction with the G-actin cytoskeleton, relevant to research on cell migration, proliferation, and differentiation markers in laboratory models.3,4
Combined Research Applications
Both peptides have been studied individually in laboratory research examining cell signaling, peptide stability, and cytoskeletal or vascular signaling markers. Combined use of the two peptides remains limited to exploratory laboratory settings, and available data on concurrent use is preliminary and not considered conclusive.
Important Notice
This product is intended solely for in vitro and in vivo (animal) laboratory research and is strictly prohibited for human or animal consumption, administration, or exposure. It is not designed for diagnostic, therapeutic, dietary, cosmetic, or veterinary purposes, and has not been evaluated for safety or efficacy in humans or animals. All handling must comply with institutional laboratory safety protocols and applicable research regulations.
Product Information
The material is supplied as a sterile white lyophilized powder. Each vial contains a total of 10 mg of peptide content, consisting of 5 mg of BPC-157 and 5 mg of Thymosin Beta 4 (TB500), prepared exclusively for laboratory reconstitution and controlled experimental evaluation.
References
1. Hsieh MJ, Lee CH, Chueh HY, et al. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci Rep. 2020;10:17078.
2. Brcic L, Brcic I, Staresinic M, Novinscak T, Sikiric P, Seiwerth S. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. J Physiol Pharmacol. 2009;60(Suppl 7):191-196.
3. Goldstein AL, Slater FD, White A. Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin). Proc Natl Acad Sci U S A. 1966;56(3):1010-7.
4. Huff T, Müller CS, Otto AM, Netzker R, Hannappel E. Beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001 Mar;33(3):205-20.
Storage Case (10)$9.99
